Profile
Lars E Gustafsson is the founder of Aerocrine AB, which was founded in 1997.
He held the title of Independent Director from 2012 to 2017.
He was also the Chief Executive Officer & Director of Attgeno AB from 2012 to 2017 and Nitrograf Bioanalys AB from 2013 to 2017.
He was a Director at Stiftelsen Lars Hiertas Minne and a Professor at Karolinska Institutet.
Dr. Gustafsson received a doctorate degree from Karolinska Institutet.
Former positions of Lars E Gustafsson
| Companies | Position | End |
|---|---|---|
| AEROCRINE AB | Founder | 2017-10-16 |
Attgeno AB
 Attgeno AB Pharmaceuticals: MajorHealth Technology ATTGENO AB develops, manufactures, and trades pharmaceutical drugs and electronic apparatus. Its product, Supernitro, is a vasodilator indicated for the treatment of acute pulmonary hypertension associated with major cardiac surgery. The company is headquartered in Stockholm, Sweden. | Chief Executive Officer | 2017-10-16 |
| Karolinska Institutet | Corporate Officer/Principal | 2017-10-16 |
| Stiftelsen Lars Hiertas Minne | Director/Board Member | 2017-10-16 |
Nitrograf Bioanalys AB
 Nitrograf Bioanalys AB Miscellaneous Commercial ServicesCommercial Services Nitrograf Bioanalys AB provides technical consulting services. | Chief Executive Officer | 2017-10-16 |
Training of Lars E Gustafsson
| Karolinska Institutet | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Aerocrine AB
 Aerocrine AB Electronic Equipment/InstrumentsElectronic Technology Aerocrine AB operates as a specialty pharmaceutical company focused on respiratory disease. The company was founded by Lars E. Gustafsson, Jon Lundberg, Kjell Alving, and Eddie Weitzberg in November 1997 and is headquartered in Uppsala, Sweden. | Electronic Technology |
Attgeno AB
Attgeno AB Pharmaceuticals: MajorHealth Technology ATTGENO AB develops, manufactures, and trades pharmaceutical drugs and electronic apparatus. Its product, Supernitro, is a vasodilator indicated for the treatment of acute pulmonary hypertension associated with major cardiac surgery. The company is headquartered in Stockholm, Sweden. | Health Technology |
| Stiftelsen Lars Hiertas Minne | |
Nitrograf Bioanalys AB
Nitrograf Bioanalys AB Miscellaneous Commercial ServicesCommercial Services Nitrograf Bioanalys AB provides technical consulting services. | Commercial Services |
- Stock Market
- Insiders
- Lars E Gustafsson
